推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Validation of the Comprehensive Icf Core Sets for Patients Receiving Rehabilitation Interventions in the Acute Care Setting

M Muller, E Grill, M Stier-Jarmer… - Journal of …, 2011 - ingentaconnect.com
... 35 (28–43) b310 V oice functions 90 20 88 10 20 (12–29) b410 Heart functions 88 2 86 1 4
(1–10) 109 62 106 59 15 (9–23) b415 b lood vessel functions 90 60 88 52 45 (34–56) 109 61
106 55 16 (10–24) 191 55 177 34 26 (20–33) b420 b lood pressure functions 91 16 87 10 ...
Cited by 1 - Related articles - All 2 versions

Stent with nested fingers for enhanced vessel coverage

DC Majercak - US Patent 7,942,920, 2011 - Google Patents
US007942920B2 (12) United States Patent Majercak (io) Patent No.: (45) Date of Patent: US
7,942,920 B2 *May 17, 2011 (54) STENT WITH NESTED FINGERS FOR ENHANCED VESSEL
COVERAGE (75) Inventor: David C. Majercak, Stewartsville, NJ (US) (73) Assignee ...
Related articles - All 3 versions

Validation of the Comprehensive Icf Core Sets for Patients in Post-acute Rehabilitation Facilities

[PDF] from medicaljournals.seM Muller, M Stier-Jarmer, M Quittan… - Journal of …, 2011 - ingentaconnect.com
... b340 Alternative vocalization functions 65 38 66 27 15 (8–26) b410 Heart functions 60 35 67
36 5 (1–14) 37 81 36 81 25 (12–42) b415 b lood vessel functions 64 69 67 60 19 (10–30) 37
68 36 53 19 (8–36) 57 49 61 41 14 (6–26) b420 b lood pressure functions 66 48 67 45 ...
Related articles - All 3 versions

Soluble endoglin specifically binds BMP9/BMP10 via its orphan domain, inhibits blood vessel formation and suppresses tumor growth

R Castonguay, ED Werner, RG Matthews… - Journal of Biological …, 2011 - ASBMB
SOLUBLE ENDOGLIN SPECIFICALLY BINDS BMP9/BMP10 VIA ITS ORPHAN DOMAIN, INHIBITS
BLOOD VESSEL FORMATION AND SUPPRESSES TUMOR GROWTH Roselyne Castonguay#,
Eric D. Werner#, Robert G. Matthews, Eleonora Presman, Aaron W. Mulivor ...
Related articles - All 2 versions

Astragaloside IV Improves Metabolic Syndrome and Endothelium Dysfunction in Fructose-Fed Rats

[PDF] from mdpi.comN Zhang, XH Wang, SL Mao… - Molecules, 2011 - mdpi.com
... 0 2 4 6 8 10 12 0 15 30 60 90 120 B lood gluc o s e du rin g gluc os e to le ra nc e te s
t (m m o l/L ) Control Fructose Fru+Astra IV 0.5 mg/kg Fru+Astra IV 2 mg/kg Time (min)
P<0.05 * * Page 5. Molecules 2011, 16 3900 2.3. Vessel Relaxation ...
Related articles - All 3 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451